YN

Yunus Noorul Ain Ansari

Active Director Director DIN 11067793
DIN 11067793 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Yunus Noorul Ain Ansari

Data last updated:

Yunus Noorul Ain Ansari is a Director at Medcip Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11067793
Primary Designation Director
Industry Pharma
First Appointment 21 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Apr 20252025Active

Board colleagues of Yunus Noorul Ain Ansari

NameDINCompanyDesignation
Shameena Roohi10724563Medcip Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medcip Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Yunus Noorul Ain Ansari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yunus Noorul Ain Ansari

Yunus Noorul Ain Ansari currently holds 1 directorship: Medcip Pharmaceuticals Private Limited (Director, since 21 Apr 2025).

Yunus Noorul Ain Ansari was first appointed on 21 Apr 2025 as Director at Medcip Pharmaceuticals Private Limited.

The current boards of Yunus Noorul Ain Ansari's companies include Shameena Roohi (Medcip Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available